Microbix Biosystems Inc. (MBX)

0.71
-0.01(-1.39%)
  • Volume:
    138,200
  • Bid/Ask:
    0.71/0.72
  • Day's Range:
    0.71 - 0.73
  • Type:Equity
  • Market:Canada
  • ISIN:CA59501P1045
  • CUSIP:59501P104

MBX Overview

Prev. Close
0.72
Day's Range
0.71-0.73
Revenue
15.67M
Open
0.73
52 wk Range
0.29-0.79
EPS
-0.03
Volume
138,200
Market Cap
88.64M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
139,227
P/E Ratio
-
Beta
-0.05
1-Year Change
121.88%
Shares Outstanding
124,848,767
Next Earnings Date
Feb. 16, 2022
What is your sentiment on Microbix Biosystems Inc.?
or
Market is currently closed. Voting is open during market hours.

Microbix Biosystems Inc. News

  • Microbix Presenting Product Results at AACC
    • ByBenzinga-

    MISSISSAUGA, Ontario, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX, OTCQX:MBXBF, Microbix®)), a life sciences innovator and exporter, announces that it...

  • Microbix Biosystems beats on revenue
    • BySeeking Alpha-

    Microbix Biosystems (MBXBF): FQ3 net income of $1.52MRevenue of $5.45M (+87.9% Y/Y) beats by $0.53M.Press ReleaseMicrobix will continue to drive sales growth across all of its...

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellSellStrong BuyStrong Buy
SummaryStrong SellStrong SellNeutralStrong BuyStrong Buy

Microbix Biosystems Inc. Company Profile

Microbix Biosystems Inc. Company Profile

Employees
69
Market
Canada

Microbix Biosystems Inc is a Canada-based life science company and manufacturer of viral and bacterial antigens and cell, culture-based biological products and technologies. The Company has developed and acquired two technologies: Kinlytic Urokinase and LumiSort. Kinlytic Urokinase is a biologic thrombolytic drug used to treat blood clots. LumiSort is a technology for ultra-rapid and efficient sorting of somatic cells that can be used to enrich cell populations of interest. The Company's catalogue of antigens covers over 30 bacterial and viral pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually-transmitted and insect-borne diseases.

Read More
  • thought on this stocks?
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.